Cargando…
An overview of biomarkers in Alzheimer’s disease
Alzheimer’s disease (AD) is the commonest progressive, dementing neurodegenerative disease in elderly, which affects innumerable people each year, and these numbers are likely to further increase as the population ages. In addition to the financial burden of AD on health care system, the disease has...
Autores principales: | Wattamwar, Pandurang R, Mathuranath, P. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039167/ https://www.ncbi.nlm.nih.gov/pubmed/21369416 http://dx.doi.org/10.4103/0972-2327.74256 |
Ejemplares similares
-
An overview of dementias
por: Mathuranath, P. S.
Publicado: (2010) -
Kinaesthetic ipsilateral and crossed extensor plantar response: A new way to elicit upgoing toe sign (Babinski response)?
por: Kuruvilla, Abraham, et al.
Publicado: (2011) -
Cerebral and Retinal Neurovascular Changes: A Biomarker for Alzheimer’s Disease
por: Ravi Teja, Karru Venkata, et al.
Publicado: (2017) -
Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
por: Bălașa, Adrian Florian, et al.
Publicado: (2020) -
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
por: Varesi, Angelica, et al.
Publicado: (2022)